Bjorn Hiller
Langenfeld, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Targeted CD47 checkpoint blockade using a mesothelin-directed antibody construct for enhanced solid tumor-specific immunotherapy.
Journal: Cancer immunology, immunotherapy : CII
Published: September 24, 2024
GMP-compliant iPS cell lines show widespread plasticity in a new set of differentiation workflows for cell replacement and cancer immunotherapy.
Journal: Stem cells translational medicine
Published: March 06, 2024
Activation of the cGAS/STING Axis in Genome-Damaged Hematopoietic Cells Does Not Impact Blood Cell Formation or Leukemogenesis.
Journal: Cancer research
Published: December 08, 2022
SIRPα-αCD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhance the clearance of AML-initiating cells.
Journal: Journal of hematology & oncology
Published: March 05, 2021
Ribonucleotide Excision Repair Is Essential to Prevent Squamous Cell Carcinoma of the Skin.
Journal: Cancer research
Published: April 13, 2018
cGAS senses long and HMGB/TFAM-bound U-turn DNA by forming protein-DNA ladders.
Journal: Nature
Published: February 14, 2017
Recognition of Endogenous Nucleic Acids by the Innate Immune System.
Journal: Immunity
Published: January 15, 2016
Mammalian RNase H2 removes ribonucleotides from DNA to maintain genome integrity.
Journal: The Journal of experimental medicine
Published: July 18, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026